New lens aims to sharpen vision after cataract surgery

NCT ID NCT07587138

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests a new trifocal intraocular lens (IOL) for people having cataract surgery. The lens is designed to help see clearly at near, intermediate, and far distances. Researchers will compare the new lens to a commercially available one in 66 participants, measuring distance vision under bright light. The trial is not yet recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
trifocal intraocular lens (IOL) implanted during cataract surgery
What this could lead to
If successful, this lens could provide clearer vision at multiple distances after cataract surgery, potentially reducing the need for glasses.
What could go wrong
This is an early-stage device comparison with only 66 participants. Results may not apply to all patients, and risks include typical surgical complications like infection or lens dislocation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asian Eye Institute

    Makati City, 1200, Philippines

  • Dr. Agarwal's Eye Hospital Limited

    Chennai, Tamil Nadu, 600018, India

  • Narayana Nethralaya

    Bangalore, 560010, India

  • Peregrine Eye Laser and Institute

    Makati City, Manila, 1209, Philippines

More trials for these conditions

Other studies related to the condition(s) this trial covers.